The FDA held its second hearing on CBD Oil Cannabis Pot Stocks Weed Aurora Tilray REIT Marijuana

The FDA again having another pubilc hearing about setting new regulations for cannabis, diving into what its regulatory strategy should address. FDA Commissioner Scott Gottlieb has expressed concerns about companies making claims of the health benefits of CBD. But he also recognizes regulations are needed to provide clarity for companies that want to market cannabis products. Potential safety issues are expected to be a major topic at the hearing.


%d bloggers like this: